Related Experiment Video

Updated: May 23, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Drak2 overexpression results in increased beta-cell apoptosis after free fatty acid stimulation

Jianning Mao1, Hongyu Luo, Jiangping Wu

  • 1Laboratory of Immunology, Centre Hospitalier de l'Université de Montréal (CHUM), Notre Dame Hospital, Montreal, Quebec, Canada.

Journal of Cellular Biochemistry
|September 9, 2008
PubMed

Insights

The serine threonine kinase Drak2 promotes islet beta-cell death when exposed to free fatty acids (FFAs). Reducing Drak2 protects beta-cells, while its overexpression worsens FFA-induced apoptosis and glucose intolerance.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • Free fatty acids (FFAs) can induce apoptosis in pancreatic islet beta-cells.
  • The role of specific kinases in FFA-induced beta-cell death is not fully understood.

Purpose of the Study:

  • To investigate the role of Drak2, a serine threonine kinase, in FFA-induced islet beta-cell apoptosis.
  • To determine the impact of Drak2 modulation on beta-cell survival and glucose homeostasis.

Main Methods:

  • Investigated Drak2 mRNA and protein levels in beta-cells following FFA stimulation.
  • Utilized siRNA to knockdown Drak2 expression and assessed apoptosis.
  • Generated transgenic mice overexpressing Drak2 to evaluate in vivo effects.
  • Assessed glucose tolerance in diet-induced obesity models.

Main Results:

  • FFA stimulation rapidly increased Drak2 mRNA and protein in islet beta-cells.
  • Drak2 knockdown significantly inhibited FFA-induced beta-cell apoptosis.
  • Overexpression of Drak2 exacerbated FFA-induced beta-cell apoptosis and reduced anti-apoptotic factors (Bcl-2, Bcl-xL, Flip).
  • Drak2 transgenic mice exhibited impaired glucose tolerance in a diet-induced obesity model.

Conclusions:

  • Drak2 plays a critical role in mediating FFA-induced beta-cell apoptosis.
  • Drak2 is detrimental to islet survival under conditions of excessive lipid exposure.
  • Targeting Drak2 may offer a therapeutic strategy for metabolic disorders involving beta-cell dysfunction.

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...